US 12043607
HDAC inhibitors and therapeutic use thereof
granted A61PA61P35/00
Quick answer
US patent 12043607 (HDAC inhibitors and therapeutic use thereof) held by Tango Therapeutics, Inc. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tango Therapeutics, Inc.
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61P, A61P35/00